RBC Capital

Company RY

Last mentioned: Mar 20, 2026

Timeline

  1. TD Cowen Conference

    AbbVie management is scheduled to speak at the TD Cowen Health Care Conference.

  2. DOJ Legal Support

    The Department of Justice backs AbbVie in its challenge against a Colorado drug discount program law.

  3. RBC Coverage Launch

    RBC Capital Markets initiates coverage with an Outperform rating, citing durable growth.

  4. Humira Exclusivity Ends

    The first biosimilar for Humira enters the U.S. market, marking the start of the 'Humira cliff'.

Stories mentioning RBC Capital 2

Markets Neutral

RBC Bullish on Eli Lilly's Retatrutide Despite Mixed Trial Data

RBC Capital maintains a positive outlook on Eli Lilly, identifying Retatrutide as a primary growth engine for the pharmaceutical giant. Despite recent mixed clinical trial results, analysts believe the drug's triple-agonist mechanism offers a significant competitive edge in the global obesity market.

2 sources
Markets Neutral

RBC Capital Bullish on AbbVie: Initiates Coverage with Outperform Rating

RBC Capital has initiated coverage of AbbVie with an 'Outperform' rating, signaling confidence in the company's ability to navigate the post-Humira landscape. Analysts believe the market has over-discounted the growth potential of AbbVie's next-generation immunology drugs and its durable aesthetics portfolio.

2 sources

About RBC Capital coverage

This page surfaces every story mentioning RBC Capital across our finance coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running finance beat. Cross-entity comparisons live on our compare view.

What you seeWhat it tells you
Story countNumber of distinct stories where RBC Capital was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.